Export Growth Cooper Pharma already operates in 24 export markets and has established Cooper International in Dubai to manage export activity across ANF, Middle East, and Europe, presenting a scalable path for expanding distributor partnerships and channel diversification.

Strategic Partnerships In addition to a robust own-brand generics portfolio, Cooper Pharma represents around a hundred licensed medicines from about twenty multinational partners, offering a dual opportunity to upsell licensed products and co-market with established global brands.

Manufacturing Capabilities With a state‑of‑the‑art manufacturing unit certified by ANSM, Saudi FDA, and GMP Morocco, there is potential to pursue additional regulatory approvals or contract manufacturing for new markets or private-label opportunities.

Scale & Reach A large local footprint (8 distribution centers plus Casablanca wholesale) combined with 1200+ employees signals strong logistics and execution capabilities to support regional hospitals, clinics, and wholesalers with reliable supply and service levels.

Digital & Analytics Adoption of Power BI, SAP, Google Cloud, and Dynamics suggests data‑driven sales and supply chain improvements; leverage analytics to target high‑yield segments, optimize pricing for licensed products, and identify regional growth opportunities.